TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,861 | -38.8% | 21,691 | 0.0% | 0.00% | – |
| Q2 2023 | $6,312 | -84.6% | 21,691 | 0.0% | 0.00% | – |
| Q1 2023 | $40,996 | +58.7% | 21,691 | +25.1% | 0.00% | – |
| Q4 2022 | $25,832 | -10.9% | 17,337 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -17.1% | 17,337 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -23.9% | 17,337 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -4.2% | 17,337 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -28.4% | 17,337 | 0.0% | 0.00% | – |
| Q3 2021 | $67,000 | -40.7% | 17,337 | 0.0% | 0.00% | – |
| Q2 2021 | $113,000 | – | 17,337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
| Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
| Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
| Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
| X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
| NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |